Pre-publication history
Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life
BMC Cancer 2012, 12:14 doi:10.1186/1471-2407-12-14
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 08 Jun 2011 | |
| Reviewer's Report | alessandra bearz | 29 Jul 2011 | |
| Reviewer's Report | David Spigel | 31 Oct 2011 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 06 Dec 2011 |
| Resubmission - Version 3 | Manuscript | Author's comment | 12 Dec 2011 |
| Editorial acceptance | 13 Dec 2011 | ||
| Published | 13 Jan 2012 |
